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Abstract
The primary role of a protein coding gene is to encode amino acids. Therefore, synonymous sites of
codons, which do not change the encoded amino acid, are regarded as evolving neutrally. However, if a
certain region of a protein coding gene contains a functional nucleotide element (e.g. splicing signals),
synonymous sites in the region may have selective pressure. The existence of such elements would be
detected by searching regions of low nucleotide substitution. We explored invariant nucleotide sequences
in 10 790 orthologous genes of six mammalian species (Homo sapiens, Macaca mulatta, Mus musculus,
Rattus norvegicus, Bos taurus, and Canis familiaris), and extracted 4150 sequences whose conservation
is signiﬁcantly stronger than other regions of the gene and named them signiﬁcantly conserved coding
sequences (SCCSs). SCCSs are observed in 2273 genes. The genes are mainly involved with development,
transcriptional regulation, and the neurons, and are expressed in the nervous system and the head and
neck organs. No strong inﬂuence of conventional factors that affect synonymous substitution was
observed in SCCSs. These results imply that SCCSs may have double function as nucleotide element
and protein coding sequence and retained in the course of mammalian evolution.
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1. Introduction
The neutral theory of molecular evolution
1,2 pre-
dicts that synonymous sites of codons are evolving
faster than non-synonymous sites because of the
smaller selective pressure. This is true in general;
however, several factors are known to inﬂuence on a
certain region of a coding sequence and suppress
synonymous substitution.
One of the well-known factors is the codon bias
towards optimum codons. Optimum codons reﬂect
the composition of genomic tRNA pool.
3–5 Because
optimum codons are advantageous for fast and accu-
rate translation, highly expressed or biologically
important genes would have more optimum codons
than others.
6–8 Changes from an optimum codon
to a non-optimum codon will be suppressed in such
genes. Because optimum codons are similar in
closely related species, highly expressed genes tend
to show similar codon usage; therefore synonymous
substitution is lowered. In fact, the requirement for
translational efﬁciency or accuracy enhances the
optimum codon usage and suppresses nucleotide
changes through purifying selection.
5,6,9–11 Codon
bias towards optimum codons is strong in fast-
growing organisms such as Escherichia coli or
Saccharomyces cerevisiae, but generally weak in
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12,13
Another factor is exonic splicing enhancer or silen-
cer, which are splicing signals embedded in
exons.
14,15 Existence of such elements lowers the
synonymous substitution.
16,17 In addition, ultracon-
served elements (UCEs), which majorly reside in
non-protein coding regions, sometimes extend to
coding regions.
18 In mammals, UCEs are reported to
exist near to or overlap with genes associated with
nucleotide binding, transcriptional regulation, RNA
recognition motif, zinc ﬁnger domain, and homeobox
domain.
18–20 Hox genes also contain long conserved
nucleotide regions other than UCEs outside the
homeobox domain.
21
Although the primary role of protein coding region
is to encode amino acids, there may be also functional
nucleotide elements embedded within coding
regions. For example, transcription-factor-binding
sites are found in coding regions,
22 messenger RNAs
are targeted by various post-transcriptional regu-
lations,
23 and the requirement for a speciﬁc second-
ary structure for RNA editing decreases synonymous
substitution.
24,25
Functional nucleotide elements are extensively
explored in the non-coding regions,
26–30 but less
studies have been done to explore probable functional
elements within the coding regions. We extracted sig-
niﬁcantly conserved coding sequences (SCCSs) from
orthologous genes of six mammalian species
(human, rhesus macaque, mouse, rat, cow, and dog),
and compared genes containing SCCSs and genes
without SCCSs. Analyses on gene ontology (GO),
InterPro codes, and KEGG pathways enlighten differ-
ence between the two gene groups. We also investi-
gated RNA secondary structures, codon preference,
GC content, exonic splicing signals, and gene
expression of SCCSs to survey the inﬂuence of these
factors.
2. Materials and methods
2.1. Genome data
We obtained peptide and nucleotide sequences of
orthologous genes of six mammalian species (Homo
sapiens, Macaca mulatta, Mus musculus, Rattus norvegi-
cus, Bos taurus, and Canis familiaris) from Ensembl
database
31 version 54 (http://May2009.archive.
ensembl.org/index.html). These species are selected
considering genome data quality and evolutionary
diversity. We selected one-to-one type single copy
orthologs and compiled 10 790 orthologous gene
sets (Supplementary ﬁle S1). We then constructed
multiple alignments of peptide sequences using
ClustalW
32 and constructed nucleotide alignments
based on the peptide alignments. From the nucleo-
tide alignments, we extracted sequences that are
invariant among all the species.
2.2. Identiﬁcation of SCCSs
We performed permutation simulation to identify
SCCSs, or abbreviated as SCCSs, which are invariant
longer than 10 codons. This length is set to conﬁne
the permutation run time within a feasible range.
For an N-codon long alignment, we generated a
non-redundant series of random numbers from 1 to
N, and permuted codon columns (rows of codons in
the same site of the alignment) according to the gen-
erated random numbers. In this process, gap sites are
ﬁxed and the rest of the sites are permuted. Then the
length and numbers of invariant sequences in the
permuted alignment are counted. We repeated this
process 500 000 times per ortholog set and took
averages of the frequency of invariant sequences. We
used the length and averaged frequency of invariant
sequences obtained from the permutation results as
random expectation, and evaluated the probability
of invariant sequences in the original alignment
based on the expectation. This approach helps ident-
ify sequences whose conservation is rare to occur in
the substitution background of each alignment.
Multiple testing correction of p-values is done by
FDR (false discovery rate).
33 Then we identiﬁed invar-
iant sequences longer than 10 codons and P, 0.01
as SCCSs.
2.3. Analysis on GO, InterPro, and KEGG pathways
Protein coding genes that contain at least one SCCS
is named SCCS genes and those that do not contain
an SCCS is named non-SCCS genes. We used Fatigo
web service (http://babelomics.bioinfo.cipf.es/
functional.html) to identify GO terms, InterPro
codes, and KEGG pathways that are signiﬁcantly
enriched with the SCCS gene group or with the non-
SCCS gene group. Fatigo accepts a list of Ensembl
gene IDs as input and provides P-values for enrich-
ment of the above terms. P-values are calculated by
Fisher’s exact test and corrected by FDR. We used
Ensembl gene IDs of H. sapiens as input and per-
formed two-tailed comparison between SCCS genes
and non-SCCS genes.
2.4. Analysis on preferred codons and average codon
degeneracy of SCCSs
We deﬁned preferred codons as the most frequently
used codons for a given amino acid referring to Codon
Usage Database (http://www.kazusa.or.jp/codon/
index.html) provided by Kazusa DNA Research
Institute. Because the codon usage pattern was
similar among the six species we used, the codon
178 Exploration for Functional Nucleotide Sequence Candidates [Vol. 18table of human was used as the representative. We
counted the number of preferred codons in a SCCS
and divided it by the codon length of the SCCS, and
then used the quotient as the ratio of preferred
codons. The average codon degeneracy is calculated
by summing up the degeneracy of each codon and
dividing it by the codon length of the SCCS.
2.5. Prediction of RNA secondary structures
We computationally predicted secondary structures
and free folding energy of SCCSs using Vienna RNA
software package
34 (http://www.tbi.univie.ac.at/
~ivo/RNA/). Because folding free energy varies
depending on the sequence length, we constructed
free energy distribution by 1000 randomly chosen
sequences for each length (33–246 nucleotides).
The P-value for a given free energy was evaluated
based on these distributions. Multi testing correction
is done by FDR.
2.6. Evaluation of exonic splicing enhancer density
We obtained 238 hexamers from RESCUE-ESE Web
Server
34 as candidates of exonic splicing enhancers.
We counted the number of the hexamers in the
SCCSs and the rest of the coding regions of the
10 790 genes (human sequences). We also measured
the total nucleotide length of the SCCS and the other
regions and applied the chi-square test for the ratio of
hexamers.
2.7. Analysis on gene expression
We used EGenetics (http://www.nhmrc.gov.au/
your_health/egenetics/index.htm) to investigate
gene expression of SCCS genes and non-SCCS genes.
Human anatomical system data, which give infor-
mation about in which organs a gene is expressed,
were obtained from EGenetics database by Ensemble
Biomart. We counted how many of SCCS genes and
non-SCCS genes are expressed in each organ and
divided the numbers by the total number of SCCS
genes and non-SCCS genes, respectively. Then we per-
formed the Fisher’s exact test to evaluate whether the
difference between SCCS and non-SCCS genes is sig-
niﬁcant. All P-values were corrected by FDR.
3. Results
3.1. Identiﬁcation of SCCSs
If an alignment has a high ratio of conservation,
long invariant sequences may occur easily, and vice
versa. Therefore, the rareness of invariant sequences
differs depending on the conservation background
in each alignment. To compensate this, we performed
permutation simulation. The idea of permutation is
to count the length and frequency of invariant
sequences after random change of loci and use the
result as the random expectation.
We used the frequency distribution of invariant
sequences in the permuted alignments as the
random expectation and evaluated probability of
invariant sequences in the original alignments, and
deﬁned invariant sequences longer than 10 codons
and whose probability is below 0.01 (corrected by
FDR) as SCCSs.
In total, 4150 SCCSs (192 306 bp) were obtained
from 2273 alignments of 10 790 orthologous gene
sets (Supplementary ﬁle S2). This occupies 0.94% of
the coding region of the 10 790 genes. Table 1
shows the number of SCCSs per gene and the
number of genes that contain that number of SCCSs.
Figure 1 is a graph of lengths and numbers of SCCSs
(grey bars). Black dots indicate the random expec-
tation obtained from the permuted alignments.
In the permuted alignments, there are 141
sequences (their total length is 5550 bp) whose prob-
ability is below 0.01, which means the region size of
SCCS is 35-fold larger than this expectation
(Supplementary ﬁle S3). The x
2 test between SCCSs
Table 1. Number of SCCSs in coding genes
Number of SCCSs
(per gene)
Number of genes
SCCS genes 1 1366
2 475
3 219
4 105
54 2
.56 6
Non-SCCS genes 8517
Figure 1. The length and number of SCCSs. X and Y-axes represent
the length and frequency of SCCSs, respectively. Grey bars show
the length and the number of SCCSs. Black dots indicate the
number of sequences with probability below 0.01 in the
permuted alignments.
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difference (P , 2.2E216).
If invariant and variant sites distributed randomly in
the original alignment, the frequency of invariant
sequences in the permuted alignments would
show similar frequency to the original alignment
because of the randomness at the start point. The
difference before and after the permutation
suggests that the distribution of invariant sites in the
original alignments is rather clustered than being
random.
3.2. GO, InterPro, and KEGG pathways enriched in
SCCS containing genes
We used Fatigo web service to investigate difference
in GO, InterPro codes, and KEGG pathways between
the SCCS genes and non-SCCS genes. The difference
was evaluated by the two-tailed Fisher’s test, and P-
values were corrected by FDR. Tables 2 and 3 show
GO terms, InterPro codes, and KEGG pathways signiﬁ-
cantly enriched (P , 0.01) in SCCS genes.
The all terms in GO Biological process section is
related to developmental process. One term of
Table 2. GO terms signiﬁcantly (P , 0.01) enriched with SCCS genes
Terms P* In SCCS containing
genes (%)
a
In non-SCCS containing
genes (%)
b
Fold
c
Biological process
GO:0035136: Forelimb morphogenesis 7.75E205 0.53 0.04 13.25
GO:0035115: Embryonic forelimb morphogenesis 2.50E204 0.48 0.04 12.00
GO:0060070: Canonical Wnt receptor signalling pathway 2.11E203 0.4 0.04 10.00
GO:0035137: Hindlimb morphogenesis 4.88E204 0.53 0.06 8.83
GO:0001702: Gastrulation with mouth forming second 1.78E203 0.44 0.05 8.80
GO:0009954: Proximal/distal pattern formation 3.80E204 0.57 0.07 8.14
GO:0031128: Developmental induction 1.03E203 0.53 0.07 7.57
GO:0048593: Camera-type eye morphogenesis 1.22E205 0.88 0.13 6.77
GO:0021510: Spinal cord development 2.37E204 0.75 0.13 5.77
GO:0031016: Pancreas development 1.85E203 0.62 0.12 5.17
Cellular components
GO:0014704: Intercalated disc 8.43E203 0.35 0.04 8.75
GO:0043198: Dendritic shaft 2.38E203 0.48 0.06 8.00
GO:0030425: Dendrite 2.38E203 2.29 1.1 2.08
GO:0043025: Neuronal cell body 2.38E203 2.24 1.11 2.02
GO:0015629: Actin cytoskeleton 1.15E203 3.39 1.8 1.88
GO:0043005: Neuron projection 1.15E203 4.09 2.32 1.76
Molecular function
GO:0035254: Glutamate receptor binding 3.41E203 0.35 0.02 17.50
GO:0005072: Transforming growth factor beta receptor,
cytoplasmic mediator activity
8.92E203 0.31 0.02 15.50
GO:0004843: Ubiquitin-speciﬁc protease activity 3.71E203 0.48 0.07 6.86
GO:0031625: Ubiquitin protein ligase binding 6.44E203 0.62 0.14 4.43
GO:0003725: Double-stranded RNA binding 6.44E203 0.62 0.14 4.43
GO:0042054: Histone methyltransferase activity 8.64E203 0.57 0.13 4.38
GO:0050825: Ice binding 6.50E211 2.86 0.76 3.76
GO:0004221: Ubiquitin thiolesterase activity 4.18E204 1.01 0.27 3.74
GO:0005199: Structural constituent of cell wall 1.34E203 0.92 0.25 3.68
GO:0003682: Chromatin binding 4.08E208 2.15 0.59 3.64
aThe percentages of SCCS genes that have the GO term.
bThe percentages of non-SCCS genes that have the GO term.
cThe fold of ‘a’ to ‘b’. Terms are listed in the descending order of the fold difference. Terms with the highest 10-folds are
shown for Biological Process and Molecular function.
*Probability for enrichment of the GO term in the SCCS group.
180 Exploration for Functional Nucleotide Sequence Candidates [Vol. 18Cellular components (GO:0014704) mediate mech-
anical and electrochemical integration between cardi-
omyocytes and the rest of the ﬁve (GO:0043198,
GO:0030425, GO:0043025, GO:0015629, and
GO:0043005) have an association with the neuron.
In the molecular function category, three terms
(GO:0004843, GO:0031625, and GO:0004221)
are related to the ubiquitin system, two
(GO:00042054 and GO:00003682) are associated
with chromatin. Ubiquitins are known to be involved
not only with protein degeneration but also with
signal transduction, chromatin modiﬁcation, and cell
cycle.
Of the ten Interpro codes listed in Table 3,
IPR001827 is related to ubiquitin and IPR002077
represents calcium channel and other eight are all
associated with DNA or RNA-binding functions that
mediate transcriptional regulation or chromatin
modiﬁcation.
Tow KEGG pathways (hsa04340 and hsa04310) in
Table 3 are developmental signalling pathways,
hsa04120 is related to the ubiquitin system, and
hsa04360 is involved in axon guidance, which well
corresponds with the GO and Interpro terms.
Table 4 shows the terms that are signiﬁcantly scarce
in SCCS genes. In contrast to Tables 2 and 3, majority
of the terms are involved with metabolic processes.
Fatigo can also explore enrichment of micro RNA
target and transcription-factor-binding sites; no sig-
niﬁcant item was found.
3.3. Overlap with UCEs
UCEs are deﬁned as nucleotide sequences that are
absolutely conserved longer than 200 bp between
orthologous regions of the human, rat and
mouse.
18,19 UCEs are found in both coding and
non-coding regions. Precedent studies report that
genes with low synonymous substitution or genes
overlapped with UCEs are associated with DNA
binding, RNA binding, transcription activity, and
Homeobox.
18,19 In our 10 790 genes, 4009 bp in
Table 3. InterPro and KEGG terms signiﬁcantly (P , 0.01) enriched with SCCS genes
Terms P* In SCCS containing genes
(%)
a
In non-SCCS containing
genes (%)
b
Fold
c
InterPro
IPR003619: MAD homology 1, Dwarﬁn-type 1.55E204 0.44 0.01 44.00
IPR001827: Homeobox protein, antennapedia type,
conserved site
1.77E203 0.44 0.04 11.00
IPR000569: HECT 1.26E205 0.75 0.07 10.71
IPR002077: Voltage-dependent calcium channel,
alpha-1 subunit
5.65E204 0.53 0.05 10.60
IPR010982: Lambda repressor-like, DNA-binding 1.49E203 0.48 0.05 9.60
IPR002343: Paraneoplastic encephalomyelitis antigen 9.91E205 0.7 0.08 8.75
IPR018359: Bromodomain, conserved site 9.75E204 0.57 0.07 8.14
IPR001487: Bromodomain 1.94E206 0.97 0.12 8.08
IPR017995: Homeobox protein, antennapedia type 7.36E204 0.62 0.08 7.75
IPR004088: K Homology, type 1 7.36E204 0.62 0.08 7.75
KEGG
hsa03018: RNA degradation 1.05E203 0.92 0.24 3.83
hsa04340: Hedgehog signalling pathway 6.75E203 0.88 0.29 3.03
hsa04520: Adherens junction 4.55E203 1.06 0.37 2.86
hsa05211: Renal cell carcinoma 9.88E203 0.92 0.33 2.79
hsa04120: Ubiquitin-mediated proteolysis 1.05E203 1.5 0.57 2.63
hsa04310: Wnt signalling pathway 2.22E204 2.07 0.79 2.62
hsa04360: Axon guidance 3.47E204 1.8 0.69 2.61
hsa04810: Regulation of actin cytoskeleton 1.07E203 2.07 0.94 2.20
hsa04010: MAPK signaling pathway 3.23E204 3.08 1.5 2.05
aThe percentages of SCCS genes that have the InterPro or KEGG term
bThe percentages of non-SCCS genes that have the InterPro or KEGG term.
cThe fold of ‘a’ to ‘b’. Terms are listed in the descending order of the fold difference.
*Probability for enrichment of the InterPro or KEGG terms in the SCCS group.
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4009 bp region, 2835 bp in 22 genes overlap with
SCCSs (Supplementary ﬁle S4). Because SCCSs are
conserved in six mammalian species, including the
three species referred for UCEs, the 2835 bp reﬂect
conservation in other three species (macaque, cow,
and dog). We surveyed nucleotide sites in the
10 790 genes that are conserved among human, rat,
and mouse, and evaluated how many of them are
also conserved in macaque, cow, and dog. The
resulted ratio is 0.751; therefore the expected conser-
vation is 3035 bp. This matches well with the obser-
vation. The regions overlapped with UCEs make only
1.47% of the entire SCCS regions. Other SCCSs
convey shorter but deeper conservation than UCEs.
3.4. SCCSs that form stable RNA secondary structures
There are cases that a secondary structure of mRNA
conveys functions.
24,25 We examined secondary struc-
tures and free energy of the SCCSs using Vienna RNA
package. We found three SCCSs whose folding
energy were signiﬁcantly low (Table 5).
Polg encodes a catalytic subunit of mitochondrial
DNA polymerase POLG. The POLG protein is the only
polymerase known to be involved in replication of
mtDNA. Gal3st3 encodes a member of the galac-
tose-3-O-sulfotransferase protein family. This protein
exists on the membrane of Golgi apparatus. Smarcd3
encodes a protein of SWI/SNF family, whose
members display helicase and ATPase activities. This
protein is thought to regulate transcription of target
genes by altering the chromatin structure around
those genes.
Table 5. Genes containing SCCS with signiﬁcantly (P , 0.001) low
free folding energy
Gene Length Free
energy
polg DNA polymerase subunit gamma-1 36 219.9
gal3st3 Galactose-3-O-sulfotransferase 3 36 222.6
smarcd3 SWI/SNF-related matrix-associated
actin-dependent regulator of
chromatin subfamily D member
39 223.9
The gene names are represented by those of human.
Table 4. GO, InterPro and KEGG terms signiﬁcantly (P , 0.01) scarce in SCCS genes
Terms P* In SCCS containing
genes (%)
a
In non-SCCS containing
genes (%)
b
Fold
c
Biological process
GO:0043039: tRNA aminoacylation 6.15E203 0.09 0.63 0.14
GO:0006725: Cellular aromatic compound metabolic process 7.31E203 0.48 1.3 0.37
GO:0051186: Cofactor metabolic process 6.05E203 0.66 1.59 0.42
GO:0055114: Oxidation-reduction process 5.86E204 2.11 3.87 0.55
GO:0019752: Carboxylic acid metabolic process 3.54E204 2.42 4.34 0.56
GO:0006082: Organic acid metabolic process 3.54E204 2.42 4.35 0.56
GO:0044255: Cellular lipid metabolic process 8.60E203 3.3 4.98 0.66
Cellular component
GO:0019866: Organelle inner membrane 2.38E203 0.66 1.72 0.38
GO:0044429: Mitochondrial part 1.27E203 1.63 3.24 0.50
GO:0005615: Extracellular space 2.87E203 2.29 3.93 0.58
Molecular function
GO:0001595: Angiotensin receptor activity 8.64E203 0 0.4 0.00
GO:0016616: Oxidoreductase activity, acting on the CH-OH
group of donors, NAD or NADP as acceptor
6.42E203 0.18 0.82 0.22
GO:0016614: Oxidoreductase activity, acting on CH-OH group
of donors
8.92E203 0.26 0.97 0.27
Interpro
IPR002198: Short-chain dehydrogenase/reductase SDR 8.96E203 0 0.46 0.00
Kegg
hsa04060: Cytokine–cytokine receptor interaction 2.86E203 0.57 1.56 0.37
aThe percentages of SCCS genes that have the GO, InterPro or KEGG term.
bThe percentages of non-SCCS genes that have the GO, InterPro or KEGG term.
cThe fold of ‘a’ to ‘b’. Terms are listed in the ascending order of the fold difference.
*Probability for enrichment of the GO, InterPro or KEGG terms in the SCCS group.
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free energy constructed by randomly extracted
sequences. Each line shows the free energy of the
sequences of the same length as the above three
SCCSs. Gene names on the lines represent free
energy of the SCCSs. This ﬁgure suggests that these
three SCCSs have extremely low free energy and that
these regions will form stable secondary structures.
These SCCSs may be conserved because of the
requirement for the secondary structures. However,
substitution restriction of this type might be modest
because a secondary structure can be retained by
another combination of nucleotides as far as the com-
plementarity is maintained.
3.5. The density of exonic splicing enhancers in SCCSs
and in the other coding regions
One of the well-known functional nucleotide
elements in the coding region is splicing signals. We
obtained 238 hexamers from RESCUE-ESE Web
server as candidates of exonic splicing enhancers,
and counted the number of hexamers in SCCSs and
non-SCCS regions of the 10 790 genes (Table 6).
Splicing signals in non-SCCS regions are counted on
human sequences. We observed 20 420 hits of
signals in 192306 bp of SCCS regions and
2 183 544 hits in 205 666 520 of non-SCCS
regions. The number of the signals per nucleotide is
both 0.106 for SCCS and non-SCCS, and there was
no signiﬁcant difference (P ¼ 0.99, x
2 test).
3.6. Gene expression
We investigated the difference of gene expression
between SCCS genes and non-SCCS genes referring
to anatomical system data of EGenetics, which give
qualitative information about in what organs a gene
is expressed. We counted the number of SCCS genes
and non-SCCS genes expressed in the organs and per-
formed the Fisher’s exact test as described in Materials
and method section.
We compared the percentages of genes that are
expressed in each organ. Table 7 shows organs in
which signiﬁcantly higher percentage of SCCS genes
are expressed compared with non-SCCS genes. In
general, SCCS genes are expressed in a wider variety
of organs. This observation agrees with a previous
study.
35 Only in medulla oblongata and trophoblast,
non-SCCS genes showed signiﬁcantly higher percen-
tage than SCCS genes (data not shown).
Seven organs (amygdala, spinal cord, cerebellum
cortex, cerebellum, frontal lobe, pituitary grand, and
sympathetic chain) in Table 7 are related with the
nervous system and six organs (cochlea, trabecular
meshwork, hypopharynx, larynx, tongue, and
thyroid) are associated with head and neck.
3.7. Preferred codons, GC content, and codon
degeneracy of SCCSs
Codon usage biases towards optimum codons are
known to suppress synonymous substitution.
Optimum codons reﬂect the composition of the
genomic tRNA pool and are advantageous for trans-
lation efﬁciency or accuracy. As the approximate
index of optimum codons, we used preferred
codons, or most frequently used codon for an amino
acid, and evaluated the preferred codon fraction in
SCCSs. In SCCS regions, 28 188 of 64 102 codons
are preferred codons and in non-SCCS regions,
2 961 482 of 6 855 505 codons are preferred
codons. The ratio of preferred codons in SCCS and
non-SCCS regions are 0.440 and 0.432, respectively.
The difference is signiﬁcant at the 0.05 signiﬁcance
level (P ¼ 0.013) but the difference of the ratios is
merely 0.008. We also observed that the ratio of pre-
ferred codon decreases as the length of SCCS increases
(Fig. 3). Judging from these results, SCCSs are unlikely
to be retained solely by codon preference.
Table 6. Splicing signals in SCCS and non-SCCS regions of 10790
genes
Region size (bp) #Splicing signals Per nucleotide
SCCS 192306 20420 0.106
Non-SCCS 20566520 2183 544 0.106
Splicing signals in non-SCCS regions are counted on human
sequences.
Figure 2. The probability density of the folding free energy. This
graph shows the probability density of the folding free energy
for 36 and 39 nucleotide-long sequences. The three SCCSs
with signiﬁcantly low free energy are indicated on the graph.
Probability density was created using software package R.
38
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nucleotide change as a result of CpG hyper mutability.
We investigated GC content of SCCSs. GC content in
the ﬁrst (GC1), second (GC2), and third position
(GC3) of codons show different patterns along the
sequence length (Fig. 4). GC1 is mostly constant but
GC2 increases while GC3 decreases as the length of
SCCS increases. Because mammalian genomes prefer
GC-ending codons, the decrease of GC3 corresponds
to the decrease of preferred codons. The decrease of
GC3 seems to be complementary with the increase
of GC2 because GC content as a whole is constant
(Supplementary Fig. S1).
Conservation of SCCSs may occur by chance in a
region where amino acid constraint is strong and
codondegeneracyislow.Weinvestigatedcodondegen-
eracy of SCCSs to examine this possibility. The average
degeneracy is between three and four and increases
as the sequence length increases (Fig. 5). This result
suggests that even if the ﬁrst and second positions of
codons are restricted, the third position has enough
freedom to change. Therefore, it is unlikely that SCCSs
are conserved because of the amino acid constraint
combined with the low degeneracy of codons.
Figure 3. The ratio of preferred codons in SCCSs. X-axis represents
the length of SCCSs, and Y-axis represents the ratio of
preferred codon of the sequences. Classes whose sample size
, 20 were combined. Error bars represent 1 SE.
Table 7. Organs in which signiﬁcantly (P , 0.001) higher percentage of SCCS genes are expressed compared with non-SCCS genes
Organ P* SCCS Non-SCCS Fold
c
#Expressed Percentage
a #Expressed Percentage
b
Amygdala 1.32E211 201 9.86 318 5.37 1.84
Cochlea 1.24E222 436 21.39 723 12.21 1.75
Small intestine 5.28E203 49 2.40 86 1.45 1.66
Amnion 1.03E204 102 5.00 183 3.09 1.62
Amniotic ﬂuid 9.12E207 175 8.59 321 5.42 1.58
Spinal cord 7.21E205 129 6.33 243 4.10 1.54
Artery 9.80E205 133 6.53 254 4.29 1.52
Cerebellum cortex 2.74E203 83 4.07 160 2.70 1.51
Cerebellum 3.62E208 277 13.59 543 9.17 1.48
Trabecular meshwork 1.38E205 199 9.76 399 6.74 1.45
Frontal lobe 1.63E228 899 44.11 1803 30.45 1.45
Hypopharynx 1.75E206 246 12.07 497 8.39 1.44
Pituitary gland 1.67E209 421 20.66 877 14.81 1.39
Sympathetic chain 9.65E206 271 13.30 575 9.71 1.37
Breast 5.95E230 1133 55.59 2430 41.04 1.35
Larynx 9.05E213 642 31.50 1385 23.39 1.35
Tongue 4.55E207 377 18.50 816 13.78 1.34
Smooth muscle 1.36E205 307 15.06 670 11.32 1.33
Thyroid 3.36E223 1076 52.80 2375 40.11 1.32
Adrenal gland 4.51E206 362 17.76 801 13.53 1.31
aThe percentages of SCCS genes that are expressed in the organ.
bThe percentages of non-SCCS genes that are expressed in the organ.
cThe fold of ‘a’ to ‘b’ Terms are listed in the descending order of the fold difference.
*Probability for enrichment of the expressed genes in the SCCS group.
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GO terms, InterPro codes, and KEGG pathways
enriched with SCCS genes show a strong commitment
to the developmental process, transcriptional regu-
lation, and the neurons. Genes associated with tran-
scriptional regulation or the neurons are known to
have a low synonymous substitution ratio. This
phenomenon is discussed in relation with codon
biases to improve translational efﬁciency or accuracy.
However, our analysis on the preferred codons in
SCCSs suggests that codon preference is not likely
the major factor inﬂuencing on the conservation of
SCCSs.
Analyses on the ratio of preferred codons, GC
content, and codon degeneracy enlighten the charac-
teristics of SCCSs. The ratio of preferred codons
decreases as the SCCS length increases. Drummond
and Wilke
36 investigated the correlation between
synonymous substitution rate (dS) and fraction of
optimum (Fop) codons, and detected negative corre-
lations between dS and Fop in rodents (mouse and
rat) and positive correlation in human–dog compari-
son. If the SCCSs have the same trend as the rodents of
the previous study, the ratio of preferred codons in
SCCSs should be high; however, our result is not.
There was no factor that would lower nucleotide sub-
stitution in GC content and codon degeneracy.
Methodological difference is that our research
focused on local and complete conservation of
nucleotides instead of the dS in the entire region of
a gene and that we investigated conservation among
the six mammalian species instead of a pair-wise
comparison. The difference of results may suggest
that factors underlying local and strong conservation
such as SCCS differ from the factors working on the
gene-wide conservation.
Makalowski et al.
37 showed a correlation between
synonymous substitution rate (dS) and non-synon-
ymous substitution rate (dN). Such correlations may
occur when the constraint on a certain nucleotide
sequence is so strong that dN is also lowered.
Figure 5. Codon degeneracy of SCCSs. X-axis represents the
length of SCCSs and Y-axis represents the averaged codon
degeneracy of the sequences. Classes whose sample size , 20
were combined. Error bars represent 1 SE.
Figure 4. GC content of the ﬁrst (GC1), the second (GC2), and the
third (GC3) position of codons in SCCSs: (A) GC1, (B) GC2, (C)
GC3. X-axis represents the length of SCCSs, and Y-axis represents
GC content of the sequences. Classes whose sample size , 20
were combined. Error bars represent 1 SE.
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conservation of SCCSs may be preferable as regulatory
signals. The fraction of SCCSs in the coding region of
the 10 790 genes is 0.94%. This fraction is so small
that it would not have an inﬂuence on conventional
evolutionary analysis. Although the fraction is small,
or because the fraction is small, SCCSs may have
potential as regulatory elements.
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